Insulin-like effect of ammonium para-tungstate on glycoprotein metabolism in streptozotocin diabetic rats

Medical Science Research

Volumn 26, Issue 8, 1998, Pages 541-544

  Palanivel, R ^a   Sundravel, S ^a   Ravichandran, P ^a   Govindasamy, S ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Ammonium para tungstate; Diabetes mellitus; Glycoprotein; Glycosylation; Streptozotocin

Indexed keywords

GLYCOPROTEIN; TUNGSTEN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RAT; STREPTOZOCIN DIABETES;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031660316     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mitlal N, Kaur J, Mahmood A. Changes in tubular membrane glycosylation in diabetic insulin and thyroxine-treated rat kidneys. lud J Exri Biol 1996; 34:782-785.
2. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes care 1992: 15:1835-1843.
3. Robinson KA, Weinstein ML, Lindenmayer GE, Bvsc MG. Effects of diabetes and hyperglycaemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 1995; 44:1438-1446.
4. Osterby R, Gundersen HJG. Fast accumulation of basement membrane material and the rats of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 1980; 18:493-504.
5. Mohanam S, Böse SM. Influence of streptozotocin and alloxan induced diabetes in the rats on collagenase and certain lysosomal enzymes in relation to degradation of connective tissue proteins. Diabetologia 1983:25:66-70.
6. Maddux BA, Sbraccia P, Kumakura S, Sasson S. Youngren J, Fisher A el al. Membrane glycoprotein PC-1 and insulin resistance in diabetes mellitus. Nature 1995; 373:448-451.
7. Rossetti L, Giaccari A, Barzilai N, Howard K. Sebel G. Hu M. Mechanisms by which hyperglycemia inhibits hepatic glucose production in conscious rats: implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest 1993; 92:1126-1134.
8. Hunt JV. Dean RT, Wolff SP. Hydroxyl radical production and autooxidative glycosylation. Glucose autooxidation as a cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 1988: 256:205-212.
9. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and biochemical basis of diabetic complication. N Engt J Med 1988: 318:1315-1322.
10. Filial C. Rodriguez-Gill JE, Guinovart JJ. Molybdatc and tungstalc act like vanadate on glucose metabolism in isolated hepatocytcs. Biochem J 1992: 282:659-663.
11. Jinping L. Erberg G, Gefel D. Sheehter Y. Permolybdate and pertungstate-potent stimulators of insulin effects in rat adipocytcs: Mechanism of action. Biochemistry 1995: 34(18):6218-6225.
12. Barbera A, Rodriguez-Gill JE, Guinovart JJ. Insulin-like actions of tungstate in diabetic rats. J Biol Clie/n 1994: 269:20047-20053.
13. Mark HF. Othmar DF, Overberger CG, Seaberg GT. Tungsten compounds. In: Encyclopedia of Chemical Technology Vol. 23. 3rd ed. New York: Wiley - Interscience; 1983; pp.426-438.
14. Maneemegalai S, Sekar N, Govindasamy S. Effect of vanadate on tissue defense system in rats with streptozotocin-induced diabetes. J Clin Biochem Nutr 1996; 20:157-164.
15. Niebes D. Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin ChimActa 1972; 42:399-408.
16. Wagner WD. More sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem 1979; 94:394-397.
17. Warren L. The thiobarbituric acid assay of sialic acid. J Biol Chem 1959; 234:1971-1975.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem 1951; 193:265-275.
19. Sasaki T, Matsui S. Effect of acetic acid concentration on the colour reaction in the ortho-toludine - boric acid method for blood glucose estimation. Rinshu Kegakum 1972; 1:346-353.
20. Morales MA, Jabbagy AJ, Terenzi HP. Mutations affecting accumulation of glycogen. Neurospora Newslett 1973; 20:24-25.
21. Mathew S, Menon PVG, Kurup PA. Changes in glycoproteins in isoproternol-induced myocardial infarction in rats. Ind J Biochem Biophys 1982; 19:41-43.
22. Crook ED, McClain DA. Regulation of glycogen synthase and protein phosphatase-1 by hexosamines. Diabetes 1996; 45:322-327.
23. Mahmood A, Torres-pinedo R. Postnatal changes in lectin binding to micro villus membranes from rat intestine. Biochem Biophys Res Commun 1983; 113:400-406.
24. McVerry BA, Hopp A, Fisher C, Huehns ER. Production of pseudodiabetic renal glomerular changes in mice after repeated injection of glycosylated proteins. Lancet 1980; 1:738-740.
25. Pathak RM, Ansari S, Mahmood A. Changes in chemical composition of intestinal brush border membrane in alloxan induced chronic diabetes. Iiul./ K.\ï> Hiol 1981; 19:503-505.
26. Guillot R, Kassab JP. Ogneva V. Andre j. Durussel J.I, Hadjiisky P el al. Relation between pancreatic islet cellular infiltration and plasma fibrinogen or alpha 1-acid glycoprotein levels in spontaneously and strepto/otocin-diabetic rats: an increase in these protein levels is not necessary for inducing microcirculalory erythroc\te velocity alteration. Pancreas 1994; 9(3):336-343.
27. Sekar N, Kanthusamy A. William S, Balusubramaniyan N. Govindasamy S. Antioxidant eft'ecl of vanadate on experimental diabetic rats. Ai-iti diabetol Lui 1990; 27:285-293.
28. Robinson KA, Sens DA, Bu.se MG. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Diabetes 1996; 45:322-327.
29. Youngren JF, Maddux BA. Sasson S, Sbraecia P, Tapscott EB, Swanson MS et ul. Skeletal muscle content of membrane glycoprotein PC-1 in obesity relationship to muscle glucose transport. Diabetes 1996; 45(10): 1324-1328.
30. Williamson JR. Kilo C. Capillary basement membranes in diabetes. Diabetes 1983: 32(2):96-100.
31. Rasch R, Torffuit O, Bachmann S, Jensen PK, Jacobsen NO. TammHorsfall glycoprotein in strepto/otocin diabetic rats: a study of kidney in situ hybridization, immuno histochemistry and urinary excretion. Diabetologia 1995: 32(5):525-535.
32. Marshall S, Bacote V. Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Bin/ Chi'm 1991 ; 266:4706-4712.
33. Tschope D. The activated megakaryocyte-platelet system in vascular disease: tows on diabetes. Semin Thromb Hemost 1995; 21(2): 152-160.
34. He R. Reid DM. Jones CE, Shulman NR. Extracellular epitopes of platelet glycoprotein Ib alpha reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura. Blood 1995;26(10):3789-3796.
35. Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW et al. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Pmc NatI Acad Sci USA 1994; 91(8):3137-3141.